Neuphoria Therapeutics Inc. (NEUP) — DEF 14A Filings
All DEF 14A filings from Neuphoria Therapeutics Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
NEUP Sets Virtual Annual Meeting, Board Seeks Re-election of Two Directors
— Oct 30, 2025 Risk: low
Neuphoria Therapeutics Inc. (NEUP) is holding its Annual Meeting of Stockholders on December 9, 2025, virtually at www.virtualshareholdermeeting.com/NEUP2025. K -
Bionomics Limited Files Definitive Proxy Statement
— Nov 12, 2024 Risk: low
Bionomics Limited filed a Definitive Proxy Statement (DEF 14A) on November 12, 2024, related to its annual meeting. The filing indicates no fee was required for
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX